To extend the function of YPFS in elevating the final intracellular cisplatin concentration in a fast-onset manner, we provided different lines of evidence of YPFS in reversing cisplatin-resistance in lung cancer cell lines by reducing the activities and expressions of ATP-binding cassette transporters, and the levels of GSTs. This evidence concerns the gene HPGDS and lung cancer.